Table 3

Comparison of clinical characteristics and assessment scale scores between patients with and without suspected COVID-19 adjusting for benzodiazepine use

Statistical methodFP value
PANSSANCOVA0.5470.463
PSSANCOVA89.83<0.001*
HAMDNon-parametric ANCOVA0.003*
HAMANon-parametric ANCOVA0.003*
PSQINon-parametric ANCOVA0.04*
  • *P<0.05.

  • ANCOVA, analysis of covariance; HAMA, Hamilton Anxiety Rating Scale; HAMD, Hamilton Depression Rating Scale; PANSS, Positive and Negative Syndrome Scale; PSQI, Pittsburgh Sleep Quality Index; PSS, Perceived Stress Scale.